These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25242652)

  • 1. Galactosylated liposome as a dendritic cell-targeted mucosal vaccine for inducing protective anti-tumor immunity.
    Jiang PL; Lin HJ; Wang HW; Tsai WY; Lin SF; Chien MY; Liang PH; Huang YY; Liu DZ
    Acta Biomater; 2015 Jan; 11():356-67. PubMed ID: 25242652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of galactose-modified liposomes as a potent antigen presenting cell targeted carrier for intranasal immunization.
    Wang HW; Jiang PL; Lin SF; Lin HJ; Ou KL; Deng WP; Lee LW; Huang YY; Liang PH; Liu DZ
    Acta Biomater; 2013 Mar; 9(3):5681-8. PubMed ID: 23159567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.
    Qu W; Li N; Yu R; Zuo W; Fu T; Fei W; Hou Y; Liu Y; Yang J
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):852-860. PubMed ID: 29447484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
    Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
    Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLs.
    Miki K; Nagaoka K; Harada M; Hayashi T; Jinguji H; Kato Y; Maekawa R
    Int Immunopharmacol; 2014 Dec; 23(2):499-504. PubMed ID: 25284343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice.
    Hattori Y; Kawakami S; Suzuki S; Yamashita F; Hashida M
    Biochem Biophys Res Commun; 2004 May; 317(4):992-9. PubMed ID: 15094367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization.
    Ishii M; Kojima N
    Glycoconj J; 2010 Jan; 27(1):115-23. PubMed ID: 19816665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface assembly of poly(I:C) on polyethyleneimine-modified gelatin nanoparticles as immunostimulatory carriers for mucosal antigen delivery.
    Lin SF; Jiang PL; Tsai JS; Huang YY; Lin SY; Lin JH; Liu DZ
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1228-1237. PubMed ID: 30339742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
    Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
    J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pH-sensitive fusogenic polymer-modified liposomes co-loaded with antigen and α-galactosylceramide as an anti-tumor vaccine.
    Okazaki S; Iwasaki T; Yuba E; Watarai S
    J Vet Med Sci; 2018 Feb; 80(2):197-204. PubMed ID: 29311431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
    Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
    PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory.
    Wang C; Liu P; Zhuang Y; Li P; Jiang B; Pan H; Liu L; Cai L; Ma Y
    Vaccine; 2014 Sep; 32(42):5475-83. PubMed ID: 25110295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
    Ko SY; Ko HJ; Chang WS; Park SH; Kweon MN; Kang CY
    J Immunol; 2005 Sep; 175(5):3309-17. PubMed ID: 16116223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
    Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
    J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity.
    Kataoka K; McGhee JR; Kobayashi R; Fujihashi K; Shizukuishi S; Fujihashi K
    J Immunol; 2004 Mar; 172(6):3612-9. PubMed ID: 15004163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
    Vadolas J; Davies JK; Wright PJ; Strugnell RA
    Eur J Immunol; 1995 Apr; 25(4):969-75. PubMed ID: 7737300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
    Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
    Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.